Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/37003287/
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with...
efficacysafetyfitusiranprophylaxispeople
https://pubmed.ncbi.nlm.nih.gov/35263495/
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs...
The B-Natural study reveals impacted QoL in all disease severities of HB including those with inhibitors. Unmet needs remain and include nonsevere HB.
haemophilia bqualitylifelargemultinational
https://pubmed.ncbi.nlm.nih.gov/35392437/
International consensus recommendations on the management of people with haemophilia B
Haemophilia B is a rare X-linked genetic deficiency of coagulation factor IX (FIX) that, if untreated, can cause recurrent and disabling bleeding, potentially...
internationalconsensusrecommendationsmanagementpeople
https://pubmed.ncbi.nlm.nih.gov/32996663/
Abnormal bleeding phenotype for mild haemophilia B patients with the p.Ile112Thr variation on the...
Abnormal bleeding phenotype for mild haemophilia B patients with the p.Ile112Thr variation on the gene for factor IX
abnormal bleedingphenotypemildhaemophiliapatients
https://pubmed.ncbi.nlm.nih.gov/11950963/
Haemophilia A and haemophilia B: molecular insights
This review focuses on selected areas that should interest both the scientist and the clinician alike: polymorphisms within the factor VIII and factor IX...
haemophiliabmolecularinsights